A detailed history of Yousif Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Yousif Capital Management, LLC holds 37,343 shares of AZN stock, worth $2.47 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
37,343
Previous 49,737 24.92%
Holding current value
$2.47 Million
Previous $3.88 Million 24.99%
% of portfolio
0.03%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$76.67 - $87.62 $950,247 - $1.09 Million
-12,394 Reduced 24.92%
37,343 $2.91 Million
Q2 2024

Jul 31, 2024

SELL
$66.81 - $80.83 $267,240 - $323,320
-4,000 Reduced 7.44%
49,737 $3.88 Million
Q1 2024

Apr 26, 2024

SELL
$61.03 - $69.57 $55,232 - $62,960
-905 Reduced 1.66%
53,737 $3.64 Million
Q4 2023

Feb 01, 2024

BUY
$61.89 - $69.28 $217,852 - $243,865
3,520 Added 6.89%
54,642 $3.68 Million
Q3 2023

Oct 30, 2023

SELL
$64.85 - $71.7 $71,010 - $78,511
-1,095 Reduced 2.1%
51,122 $3.46 Million
Q2 2023

Aug 02, 2023

BUY
$69.91 - $75.81 $14,820 - $16,071
212 Added 0.41%
52,217 $3.74 Million
Q1 2023

May 02, 2023

BUY
$63.15 - $71.6 $13,261 - $15,035
210 Added 0.41%
52,005 $3.61 Million
Q3 2022

Nov 04, 2022

BUY
$53.02 - $135.75 $53,550 - $137,107
1,010 Added 1.99%
51,795 $2.84 Million
Q2 2022

Aug 01, 2022

BUY
$59.26 - $71.14 $150,520 - $180,695
2,540 Added 5.26%
50,785 $3.36 Million
Q4 2021

Jan 31, 2022

BUY
$54.02 - $63.83 $2.61 Million - $3.08 Million
48,245 New
48,245 $2.81 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.